{
    "2018-04-25": [
        [
            {
                "time": "",
                "original_text": "市场偏爱有加！医药股再度起飞 券商持续关注这些股",
                "features": {
                    "keywords": [
                        "市场",
                        "医药股",
                        "券商"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[推荐评级] 医药行业周报：机构配置提升 性价比仍有优势",
                "features": {
                    "keywords": [
                        "推荐评级",
                        "医药行业",
                        "机构配置",
                        "性价比"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "尔康制药：2017年净利润5.22亿 研发创新驱动业绩持续增长",
                "features": {
                    "keywords": [
                        "尔康制药",
                        "净利润",
                        "研发创新",
                        "业绩增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "尔康制药2017年营收28.28亿元 新业务或在2018年迎来转机",
                "features": {
                    "keywords": [
                        "尔康制药",
                        "营收",
                        "新业务",
                        "转机"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "受益医保、招标 二线品种高增长",
                "features": {
                    "keywords": [
                        "医保",
                        "招标",
                        "二线品种",
                        "高增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "进口药能否抢占国产药地盘",
                "features": {
                    "keywords": [
                        "进口药",
                        "国产药",
                        "竞争"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "大单抢筹致两市普涨 40亿元北上资金抄底搏反弹",
                "features": {
                    "keywords": [
                        "大单抢筹",
                        "两市普涨",
                        "北上资金",
                        "抄底",
                        "反弹"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}